Summary.-The effect of various glycosidases on the growth of solid hypotetraploid Ehrlich ascites tumour was investigated. The purified bacterial chondroitinase-ABC significantly inhibited the growth of tumour; chondroitinase-AC inhibited the tumour to some extent but chondro-4-sulphatase, chondro-6-sulphatase, streptomyces hyaluronidase, and f-glucuronidase had no inhibitory effect. Heat-treated chondroitinase-ABC had no inhibitory effect on the tumour growth. The growth of tumour cells which were injected subcutaneously after in vitro incubation with chondroitinase-ABC or -AC solution was decreased when compared with that of sham-treated cells.
CHONDROITIN sulphate C promotes the growth of solid Ehrlich ascites tumour in viro, which correlates with the concentration of chondroitin sulphate used (Takeuchi, 1965 (Takeuchi, , 1966a (Takeuchi, , 1966b (Takeuchi, , 1971 . Recently, Yamagata et al. (1968) purified chondroitinase -ABC, chondro -4 -sulphatase and chondro-6-sulphatase from extracts of Proteus vularis, and chondroitinase-AC from extracts of Flavobacterium heparinuam. Suzuki, Kojima and Utsumi (1970) demonstrated the production of chondroitin sulphates and dermatan sulphate by HeLa-S3 and L-929 cells, and they also found that the surface negativity of these cells was reduced by chondroitinase-ABC treatment. Kojima and Yamagata (1971) , using the same enzyme, reported that sulphated mucopolysaccharides were located on the surface of hepatoma cells.
The purpose of this study was to elucidate in greater detail the growthstimulating effect of acid mucopolysaccharides. Effects of purified chondroitinase-ABC, -AC, chondro-4-sulphatase, chondro-6-sulphatase, streptomyces hyaluronidase, 8-glucuronidase, and chondroitin sulphates A, B and C on the growth of solid Ehrlich ascites tumour were tested as previously described (Takeuchi, 1965 (Takeuchi, , 1966a (Takeuchi, , 1966b (Takeuchi, , 1968 (Takeuchi, , 1971 .
MATERIALS AND METHODS
Animals used throughout this experiment were male ddN mice aged 60-70 days, obtained from Nihon Clea Co. Ltd., Tokyo. They were fed with a standard pellet (CA-1, Nihon Clea Co. Ltd., Tokyo) and given drinking water ad libitum.
The Ehrlich hypotetraploid tumours (Kaziwara 4N) (Kaziwara, 1954) were supplied by Dr M. Kodama, Aichi Cancer Centre Research Institute. They were maintained in adult male ddN mice through serial intraperitoneal transplantation at 7-or 8-day intervals.
One ml of the substances tested was injected subcutaneously into the back of each mouse, immediately followed by injection of 0 05 ml of the Ehrlich tumour ascitic fluid, containing 1 x 107 cells. Controls were injected with isotonic saline before the tumour inoculation. Animals were killed on the 8th day after tumour inoculation, and the solid tumour which developed subcutaneously was excised and weighed. The results of experiments were evaluated on the basis of average weight of tumour tissues in the experimental groups and the control groups.
In other experiments, tumour cell suspensions (1 X 107 cells/0-5 ml) were prepared by incubating the tumour ascitic fluid with the test material solution at 37°C for 30 min; 0 5 ml of this tumour suspension was then inoculated subcutaneously into the back of each mouse. Controls were injected with isotonic saline or buffered Veronal in saline (pH 8-0).
The viability of tumour cells was compared between the two groups by using the neutral red exclusion test.
The following materials were tested as growth inhibitors of solid Ehrlich ascites tumours: chondroitin sulphate C (average molecular weight about 50,000) from Kaken Yakukako Co., Tokyo; chondroitin sulphate B (average molecular weight about 20,000), chondroitin sulphate A (average molecular weight 40,000-80,000), chondroitinase-ABC (from Proteus vtulgaris), chondroitinase-AC (From Flavobacterium heparinum), chondro-4-sulphatase and chondro-6-sulphatase (from Proteus vulgaris) and hyaluronidase [AMANO] (from Streptomyces hyaluronicus nov. sp.) (Ohya and Kaneko, 1970) from Seikagaku Kogyo Co. Ltd., Tokyo; f-glucuronidase (17 U/g) from Worthington Biochemical Co. These materials were dissolved in isotonic saline or 0 05 mol/l Veronal buffered saline (pH 8-0). The chondroitinases containing no contaminating enzymes were purified as described in the papers by Yamagata et al. (1968) and Suzuki et al. (1968) .
RESULTS
Effect of chondroitinase-ABC.-Injection of 1 ml of chondroitinase-ABC (0-5-5-0 U/ml) solution prior to tumour inoculation significantly inhibited tumour growth as shown in Table I tumour weight in the chondroitinase-ABC-treated group was about one half as great as that in the control group; the difference between experimental and control groups being statistically significant. Heat-treated chondroitinase-ABC solution, which was kept at 60°C for 60 min before use, had no inhibitory effect on the tumour growth. Table II shows that growth of tumour cells previously incubated with chondroitinase-ABC solution in vitro was also inhibited. After the in vitro incubation, no difference in viability between the enzyme-and shamtreated cells was revealed by the neutral red exclusion test. Effect of chondroitinase-AC, chondro-4-sulphatase and chondro-6-sulphatas«e.-JInjection of 1 ml of chondroitinase-AC prior to tumour inoculation into the same site inhibited the tumour growth to some extent (Table I) . Inhibitory effect of chondroitinase-AC on the tumour growth was also observed after the pre-incubation of cells in vitro (Table II) . However, no inhibitory effect of chondro-4-sulphatase and chondro-6-sulphatase on the tumour growth was observed under any conditions (Table I) .
Effect of streptomyces hyaluronidase and /3-glucuronidase.-Streptomyces hyaluronidase and fl-glucuronidase had no inhibitory effect on the tumour growth (Table  I) . Effect of chondroitin sulphates A,-B and C.-The injection of 1 ml of chondroitin sulphate A and condroitin sulphate C solution prior to tumour inoculation promoted tumour growth, whereas chondroitin sulphate B exhibited no growthpromoting effect (Table III) . DISCUSSION Present data indicate that chondroitinase-ABC and -AC inhibit the growth of solid Ehrlich ascites tumour, and that chondro-4-sulphatase, chondro-6-sulphatase, streptomyces hyaluronidase and ,?-glucuronidase have no inhibitory effect on tumour growth. Yamagata et al. (1968) determined that the optimal pH for the degradation of chondroitin sulphates A, B and C by purified preparation of chondroititliase-ABC was between 7 0-9-0. In this experiment there was no difference in the inhibitory effect of chondroitinase-ABC between Veronal buffer solution (pH 8.0) and saline solution of it (pH about 6.5).
Recently, Kojima and Maekawa (1970) and Kojima and Yamagata (1971) revealed that chondroitinase causes a reduction of electrophoretic mobility as well as the release of chondroitin sulphates from the surface of AH 130 cells; their data also demonstrated the presence of chondroitin sulphate A and chondroitin sulphate C at the surface of tumour cells. Suzuki et al. (1970) , studying the effect of chondroitinase-treatment on the cell surface of demonstrated that chondroitin sulphates A and C and dermatan sulphate are major constituents of the cell surface and suggested that they play an important role in ensuring the normal surface character of the cells. Ozzello, Lasfargeus and Murray (1960) ascribed the growth-promoting activity of acid mucopolysaccharides to the negative electric charge and the viscosity. Morrison et al. (1965) , demonstrating the growth -stimulating action of small amounts of chondroitin sulphate A in several types of cells in vitro, considered that chondroitin sulphate may be a metabolic agent in the regulation of cell processes. Lippman (1968) described that treatment of Moloney-induced tumour with heparin and other acid mucopolysaccharides blocked cell surface antigens thereby altering transplantation behaviour. The data in these experiments reveal that chondroitin sulphate A and chondroitin sulphate C stimulate tumour growth, and that chondroitinase-ABC and -AC inhibit the tumour growth in vivo and after pre-incubation in vitro, even though no difference in viability between the chondroitinase-ABC-treated cells and sham-treated cells was revealed by the neutral red exclusion test. From these results it is conceivable that chondroitin sulphate serves as a growth supporter which protects the surface of tumour cells and promotes the physiological surface function of the cells.
